logo

Becton, Dickinson And Company (BDX)



Trade BDX now with
  Date
  Headline
6/4/2019 7:00:42 AM BD Releases New Report Based On An Independent National Survey That Examines Drug Diversion In U.S. Hospitals
5/20/2019 4:28:31 AM Becton, Dickinson And Company Begins Tender Offers For Outstanding Debt Securities
5/9/2019 6:15:03 AM BD Updates 2019 Outlook
5/9/2019 6:01:33 AM BD Q2 Loss Per Share $0.07; Adj EPS $2.59
4/30/2019 7:00:38 AM BD Receives FDA Approval For BD ChloraPrep Skin Preparation With Sterile Solution
4/29/2019 4:17:16 PM Becton, Dickinson and Company (BDX) Declares Quarterly Dividend of $ 0.77, Record Date 6/7/2019
4/8/2019 7:00:43 AM BD Reports Global Availability Of BD BACTEC Platelet Quality Control Media
3/26/2019 7:01:57 AM BD Launches New Automated Flow Cytometry Sample Preparation Instrument With CE-IVD Certification
3/14/2019 7:00:12 AM BD Secures FDA Approval For First Venous Stent To Treat Iliofemoral Venous Occlusive Disease
2/5/2019 6:01:05 AM BD Q1 EPS $2.05 Vs Loss $0.76 Last Year
1/24/2019 7:02:09 AM BD Unveils Ergonomic Pen Needle Technology To Help Optimize Injection Technique
1/21/2019 11:08:55 PM BD Declares Quarterly Dividend Of $0.77/Shr; Record Mar 8/Payable Mar 29